Centro Integral Oncológico Clara Campal

Madrid 28050

0 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer, Multiple Myeloma, Neoplasms, Non-Small Cell Lung Cancer Metastatic, Prostate Cancer Metastatic

Studies at this site

• A Study of Daratumumab — Running, not enrolling
• Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination — Running, not enrolling
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed